FindTrial
Sign In

Usefulness of medicines from Ranunculaceae family in cases of Migraine

Utility of remedies from Ranunculaceae family in cases of Migraine - Nil

Status
Active, not recruiting
Phases
Phase 2
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2024/05/068110
Enrollment
40
Registered
2024-05-30
Start date
Unknown
Completion date
Unknown
Last updated
2026-06-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: G439- Migraine, unspecified

Interventions

Intervention1: Homoeopathic medicines from RANUNCULACEAE family: Potency various decimal centesimal fifty millesimal Dose as per requirement of case Frequency as per requirement of case Route of Ad

Sponsors

Dr jigar Parikh
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Already diagnosed cases of migraine Age group: 12 ââ?¬â?? 65 years Sex: Male, Female and Transgender Pain severity more than 5 on eleven-point pain scale MIDAS disability score less than 20

Exclusion criteria

Exclusion criteria: Co morbid gross pathology of CNS Severe disability or equal to 20 on MIDAS Pregnancy and lactating female Patients who are not able to fill Eleven point pain scale and MIDAS Status migrainosus persistent aura without infarction migrainosus infarction and migraine aura triggered seizure

Design outcomes

Primary

MeasureTime frame
Eleven ââ?¬â?? point pain scaleTimepoint: data will be taken at baseline and at end of treatment of eight months of duration to assess changes—

Secondary

MeasureTime frame
MIDAS scoreTimepoint: Data will be taken at baseline of treatment andÃ?  at end of treatment of eight months of duration to assess changes—

Countries

India

Contacts

Public ContactDr Jigar Parikh

SMT A J Savala Homoeopathic medcal college and research institute Mehsana Gujarat

nisha.mehul26@gmail.com9974342824

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Jun 11, 2026